Free Trial
The Market Does Not Wait. MarketBeat All Access for Just $149
Get the Deal
Claim MarketBeat All Access Sale Promotion

Cardinal Health (CAH) Stock Forecast & Price Target

Cardinal Health logo
$200.68 +1.45 (+0.73%)
Closing price 05/21/2026 03:59 PM Eastern
Extended Trading
$201.50 +0.82 (+0.41%)
As of 04:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Cardinal Health - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Sell
0
Hold
2
Buy
16

Based on 18 Wall Street analysts who have issued ratings for Cardinal Health in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 18 analysts, 2 have given a hold rating, 15 have given a buy rating, and 1 has given a strong buy rating for CAH.

Consensus Price Target

$241.80
20.49% Upside
According to the 18 analysts' twelve-month price targets for Cardinal Health, the average price target is $241.80. The highest price target for CAH is $275.00, while the lowest price target for CAH is $170.00. The average price target represents a forecasted upside of 20.49% from the current price of $200.68.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for CAH and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Cardinal Health and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CAH Analyst Ratings Over Time

TypeCurrent Forecast
5/22/25 to 5/22/26
1 Month Ago
4/22/25 to 4/22/26
3 Months Ago
2/21/25 to 2/21/26
1 Year Ago
5/22/24 to 5/22/25
Strong Buy
1 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
15 Buy rating(s)
14 Buy rating(s)
14 Buy rating(s)
10 Buy rating(s)
Hold
2 Hold rating(s)
2 Hold rating(s)
2 Hold rating(s)
4 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$241.80$244.33$244.20$146.43
Forecasted Upside20.49% Upside22.00% Upside8.91% Upside-3.92% Downside
Consensus RatingModerate BuyModerate BuyModerate BuyModerate Buy

CAH Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CAH Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Cardinal Health Stock vs. The Competition

TypeCardinal HealthMedical CompaniesBroader Market
Consensus Rating Score
2.94
2.29
2.52
Consensus RatingModerate BuyHoldModerate Buy
Predicted Upside20.49% Upside1,714.86% Upside16.00% Upside
News Sentiment Rating
Positive News

See Recent CAH News
Neutral News
Positive News
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
5/19/2026 DowngradeBuy (B+)Buy (B)
5/4/2026
Lisa Gill
Lisa Gill
3 of 5 stars
Lower TargetNeutral$243.00 ➝ $215.00+9.16%
5/1/2026
TD Cowen logo
TD Cowen
3 of 5 stars
Charles Rhyee
Charles Rhyee
Not Rated
Boost TargetBuy$251.00 ➝ $255.00+31.40%
5/1/2026 Set Target$248.00+27.79%
5/1/2026Lower TargetBuy$249.00 ➝ $245.00+26.81%
5/1/2026Lower TargetOverweight$256.00 ➝ $245.00+25.57%
4/28/2026Initiated CoverageOutperform
4/28/2026 Boost TargetOverweight$245.00 ➝ $255.00+25.90%
4/8/2026Lower TargetOutperform$260.00 ➝ $240.00+11.48%
3/9/2026Reiterated RatingOutperform$275.00+23.70%
2/24/2026Boost TargetOverweight$243.00 ➝ $258.00+14.75%
2/12/2026 UpgradeHoldStrong-Buy
2/11/2026 Boost TargetBuy$232.00 ➝ $248.00+12.31%
2/6/2026Set TargetBuy$260.00+14.00%
2/6/2026Boost TargetOutperform$222.00 ➝ $235.00+3.17%
1/22/2026Boost TargetBuy$220.00 ➝ $270.00+29.34%
11/18/2025 Boost TargetHold$195.00 ➝ $208.00+0.61%
6/10/2025Boost TargetBuy$165.00 ➝ $170.00+10.65%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 04:17 AM ET.


Should I Buy Cardinal Health Stock? CAH Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Thursday, May 21, 2026. Please send any questions or comments about these Cardinal Health pros and cons to contact@marketbeat.com.

Cardinal Health
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Cardinal Health, Inc.:

  • Analysts maintain a generally positive outlook, with several firms recently raising their price targets, indicating confidence in the company's future performance.
  • The current stock price is around $245, reflecting a stable position in the market despite recent fluctuations.
  • Cardinal Health, Inc. has reported strong earnings per share (EPS) performance, which can signal profitability and operational efficiency to investors.
  • The company has a diverse range of services that support various sectors within healthcare, which can provide resilience against market volatility.
  • Recent guidance from management suggests an optimistic outlook for future growth, which can attract long-term investors.

Cardinal Health
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Cardinal Health, Inc. for these reasons:

  • Recent revenue figures missed expectations, which can lead to short-term selling pressure and indicate potential challenges in meeting market demands.
  • GAAP results showed a decline in operating earnings and EPS, primarily due to a significant goodwill impairment charge, which can raise concerns about the company's financial health.
  • The mixed nature of recent financial reports, with strong EPS but weak revenue, may create uncertainty and volatility, potentially deterring some investors.
  • Market reactions to earnings reports have been negative, suggesting that investor sentiment may be cautious in the near term.
  • Short-term selling pressure following earnings announcements can lead to increased volatility, which may not align with the risk tolerance of all investors.

CAH Forecast - Frequently Asked Questions

According to the research reports of 18 Wall Street equities research analysts, the average twelve-month stock price forecast for Cardinal Health is $241.80, with a high forecast of $275.00 and a low forecast of $170.00.

18 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cardinal Health in the last twelve months. There are currently 2 hold ratings, 15 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" CAH shares.

According to analysts, Cardinal Health's stock has a predicted upside of 20.49% based on their 12-month stock forecasts.

Over the previous 90 days, Cardinal Health's stock had 1 upgrade and 1 downgrade by analysts.

Cardinal Health has been rated by research analysts at Barclays, Citigroup, Evercore, JPMorgan Chase & Co., Leerink Partners, Morgan Stanley, Robert W. Baird, TD Cowen, Weiss Ratings, Wells Fargo & Company, and William Blair in the past 90 days.

Analysts like Cardinal Health more than other "medical" companies. The consensus rating for Cardinal Health is Moderate Buy while the average consensus rating for "medical" companies is Hold. Learn more on how CAH compares to other companies.


This page (NYSE:CAH) was last updated on 5/22/2026 by MarketBeat.com Staff.
From Our Partners